---
schema_version: "secwatch.filing_event.v1"
accession: "0001161697-25-000371"
form_type: "8-K"
ticker: "KRMD"
cik: "0000704440"
company_name: "KORU Medical Systems, Inc."
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T21:55:11.696063+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# KORU Medical Q3 revenue $10.4M (+27% YoY), raises full-year guidance

## Summary
- Q3 net revenues $10.4M, up 27% YoY; core business (domestic + international) $9.8M, up 30%.
- Net loss narrowed 51% to $0.8M; positive adjusted EBITDA of $0.09M vs. $(0.4M) prior year.
- International core revenue surged 229.6% to $3.7M; domestic core declined 5.0%.
- Raising FY2025 revenue guidance to $40.5-41.0M (from $39.5-40.5M); gross margin guidance reiterated at 61-63%.
- Ending cash balance $8.5M; generated $0.4M cash in Q3; reiterating positive full-year cash flow.

## SEC filing metadata
- accession: 0001161697-25-000371
- form_type: 8-K
- ticker: KRMD
- cik: 0000704440
- company_name: KORU Medical Systems, Inc.
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/704440/000116169725000371/0001161697-25-000371-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/704440/000116169725000371/form_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001161697-25-000371
- JSON: https://secwatch.observer/filing/0001161697-25-000371.json
- Plain text: https://secwatch.observer/filing/0001161697-25-000371.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.